RASSF5
Basic information
Region (hg38): 1:206507531-206589448
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RASSF5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 27 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 27 | 0 | 0 |
Variants in RASSF5
This is a list of pathogenic ClinVar variants found in the RASSF5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-206507696-G-C | not specified | Uncertain significance (May 26, 2023) | ||
1-206507712-C-T | not specified | Uncertain significance (Nov 18, 2023) | ||
1-206507714-C-G | not specified | Uncertain significance (Jul 20, 2022) | ||
1-206507732-C-T | not specified | Uncertain significance (Jan 22, 2024) | ||
1-206507736-G-T | not specified | Uncertain significance (Feb 10, 2022) | ||
1-206507742-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
1-206507747-C-A | not specified | Uncertain significance (Apr 20, 2023) | ||
1-206507762-C-T | not specified | Uncertain significance (Oct 27, 2023) | ||
1-206507769-C-A | not specified | Uncertain significance (May 24, 2024) | ||
1-206507769-C-G | not specified | Uncertain significance (Jul 11, 2022) | ||
1-206507780-C-G | not specified | Uncertain significance (Nov 13, 2023) | ||
1-206507786-G-A | not specified | Uncertain significance (Nov 28, 2023) | ||
1-206507804-G-T | not specified | Uncertain significance (Mar 06, 2023) | ||
1-206507834-C-G | not specified | Uncertain significance (Jun 11, 2024) | ||
1-206507840-G-A | not specified | Uncertain significance (Jul 06, 2021) | ||
1-206507843-C-G | not specified | Uncertain significance (Jul 25, 2023) | ||
1-206507886-C-T | not specified | Uncertain significance (May 06, 2024) | ||
1-206507946-T-G | not specified | Uncertain significance (Jan 26, 2022) | ||
1-206507967-G-A | not specified | Uncertain significance (May 21, 2024) | ||
1-206538201-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
1-206538206-C-G | not specified | Uncertain significance (Mar 23, 2022) | ||
1-206538247-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
1-206583317-G-A | not specified | Uncertain significance (Apr 24, 2024) | ||
1-206583351-G-A | not specified | Uncertain significance (Jul 06, 2021) | ||
1-206584514-C-T | not specified | Uncertain significance (Feb 15, 2023) |
GnomAD
Source:
dbNSFP
Source:
- Function
- FUNCTION: Potential tumor suppressor. Seems to be involved in lymphocyte adhesion by linking RAP1A activation upon T-cell receptor or chemokine stimulation to integrin activation. Isoform 2 stimulates lymphocyte polarization and the patch-like distribution of ITGAL/LFA-1, resulting in an enhanced adhesion to ICAM1. Together with RAP1A may participate in regulation of microtubule growth. The association of isoform 2 with activated RAP1A is required for directional movement of endothelial cells during wound healing. May be involved in regulation of Ras apoptotic function. The RASSF5-STK4/MST1 complex may mediate HRAS and KRAS induced apoptosis. {ECO:0000269|PubMed:12676952, ECO:0000269|PubMed:12845325, ECO:0000269|PubMed:15569673}.;
- Pathway
- Non-small cell lung cancer - Homo sapiens (human);Rap1 signaling pathway - Homo sapiens (human);Ras signaling pathway - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Cellular senescence - Homo sapiens (human);Leukocyte transendothelial migration - Homo sapiens (human);Fibrin Complement Receptor 3 Signaling Pathway;Ras Signaling;TCR signaling in naïve CD8+ T cells;TCR signaling in naïve CD4+ T cells
(Consensus)
Haploinsufficiency Scores
- pHI
- 0.157
- hipred
- Y
- hipred_score
- 0.662
- ghis
- 0.444
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.743
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rassf5
- Phenotype
- neoplasm; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); renal/urinary system phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- apoptotic process;negative regulation of cell population proliferation;positive regulation of protein ubiquitination;intracellular signal transduction;regulation of apoptotic process;regulation of protein localization to nucleus
- Cellular component
- nucleus;cytoplasm;microtubule
- Molecular function
- protein binding;Ras GTPase binding;metal ion binding